Quality of life in patients with ovarian cancer

Sally Elizabeth Jensen; David Cella

doi:10.1007/978-1-4614-8271-0_14

Quality of life in patients with ovarian cancer

Sally Elizabeth Jensen^*, David Cella

^*Corresponding author for this work

Medical Social Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Research examining outcomes in ovarian cancer has evolved from concentrating on more traditional clinical end points to also emphasizing quality of life (QOL). Both disease- and treatment-related factors may result in QOL decrements. Thus, QOL represents an important consideration in ovarian cancer treatment decision-making. This chapter reviews the physical, psychological, and sexual concerns that may influence QOL, as well as advances in the measurement of patient-reported QOL in ovarian cancer. The chapter discusses QOL in the context of recent treatment advances and highlights the need for future randomized controlled trials to assess the effects of intervention trials on QOL.

Original language	English (US)
Title of host publication	Advances in Diagnosis and Management of Ovarian Cancer
Publisher	Springer US
Pages	241-260
Number of pages	20
ISBN (Electronic)	9781461482710
ISBN (Print)	1461482704, 9781461482703
DOIs	https://doi.org/10.1007/978-1-4614-8271-0_14
State	Published - Jan 1 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-8271-0_14

Fingerprint Dive into the research topics of 'Quality of life in patients with ovarian cancer'. Together they form a unique fingerprint.

Cite this

@inbook{3b331fe80b3b4d2dbc2c3e47378ec828,

title = "Quality of life in patients with ovarian cancer",

abstract = "Research examining outcomes in ovarian cancer has evolved from concentrating on more traditional clinical end points to also emphasizing quality of life (QOL). Both disease- and treatment-related factors may result in QOL decrements. Thus, QOL represents an important consideration in ovarian cancer treatment decision-making. This chapter reviews the physical, psychological, and sexual concerns that may influence QOL, as well as advances in the measurement of patient-reported QOL in ovarian cancer. The chapter discusses QOL in the context of recent treatment advances and highlights the need for future randomized controlled trials to assess the effects of intervention trials on QOL.",

author = "Jensen, {Sally Elizabeth} and David Cella",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4614-8271-0_14",

language = "English (US)",

isbn = "1461482704",

pages = "241--260",

booktitle = "Advances in Diagnosis and Management of Ovarian Cancer",

publisher = "Springer US",

}

TY - CHAP

T1 - Quality of life in patients with ovarian cancer

AU - Jensen, Sally Elizabeth

AU - Cella, David

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Research examining outcomes in ovarian cancer has evolved from concentrating on more traditional clinical end points to also emphasizing quality of life (QOL). Both disease- and treatment-related factors may result in QOL decrements. Thus, QOL represents an important consideration in ovarian cancer treatment decision-making. This chapter reviews the physical, psychological, and sexual concerns that may influence QOL, as well as advances in the measurement of patient-reported QOL in ovarian cancer. The chapter discusses QOL in the context of recent treatment advances and highlights the need for future randomized controlled trials to assess the effects of intervention trials on QOL.

AB - Research examining outcomes in ovarian cancer has evolved from concentrating on more traditional clinical end points to also emphasizing quality of life (QOL). Both disease- and treatment-related factors may result in QOL decrements. Thus, QOL represents an important consideration in ovarian cancer treatment decision-making. This chapter reviews the physical, psychological, and sexual concerns that may influence QOL, as well as advances in the measurement of patient-reported QOL in ovarian cancer. The chapter discusses QOL in the context of recent treatment advances and highlights the need for future randomized controlled trials to assess the effects of intervention trials on QOL.

UR - http://www.scopus.com/inward/record.url?scp=84929527689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929527689&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8271-0_14

DO - 10.1007/978-1-4614-8271-0_14

M3 - Chapter

AN - SCOPUS:84929527689

SN - 1461482704

SN - 9781461482703

SP - 241

EP - 260

BT - Advances in Diagnosis and Management of Ovarian Cancer

PB - Springer US

ER -